JANUS HENDERSON GROUP PLC - 31 Dec 2024 SCHEDULE 13G Report for Entrada Therapeutics, Inc. Common Stock (TRDA)

Filing Manager
JANUS HENDERSON GROUP PLC
Reporting Manager
JANUS HENDERSON GROUP PLC
Security
Entrada Therapeutics, Inc. Common Stock
Symbol
TRDA
Shares outstanding
37,149,411 shares
Disclosed Ownership
2,080,367 shares
Ownership
5.6%
Form type
SCHEDULE 13G
Filing time
14 Feb 2025, 11:25:48 UTC
Date of event
31 Dec 2024
Next filing
14 May 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
JANUS HENDERSON GROUP PLC 5.6% 2,080,367 0 2,080,367 Kristin Mariani Head of North America Compliance, CCO
Janus Henderson Biotech Innovation Master Fund Ltd 5% 1,884,826 0 1,884,826 Kristin Mariani Head of North America Compliance, CCO